The Bioprocessing Summit will be a virtual event for 2020
Gene Therapy CMC and Analytics: Regulation and Analysis of Vector-Based Gene Therapies
Dr Damian Marshall, Director New Technologies
"The Role of “Big Data” and Process Analytical Technologies in Viral Vector Manufacture"
11.05-11.25, Thursday 27 August
Gene Therapy Manufacturing: Scaling up and Supplying Vector-Based Gene Therapies
Dr Mike Delahaye, Head of Viral Vector Industrialisation
"Development of a Next-Generation AAV Manufacturing Platform"
10.25-10.45, Friday 28 August
View the full agenda and more information here